Observational studyPrimary care diabetes2021

Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Denmark/Sweden multicentre, prospective, observational study.

Neda Rajamand Ekberg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.